Kymera Therapeutics, Inc.

KYMR·NASDAQ·$80.77Share Price as of 11/2·$7BMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2511/04/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report08/05/26 8-KCurrent report07/27/26 8-KCurrent report06/25/26 8-KCurrent report06/24/26

Prospectuses and Registrations

424B3Prospectus02/26/26 424B5Prospectus supplement02/26/26 S-8Registration of securities for employees02/26/26 424B5Prospectus supplement12/10/25 424B5Prospectus supplement12/08/25

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/24/24

Ownership

SC 13G/ABeneficial ownership (amended)10/27/26 144Proposed sale of securities10/01/26 Form 4Insider transaction10/01/26 SC 13G/ABeneficial ownership (amended)09/08/26 144Proposed sale of securities09/04/26

Other

ARSAnnual report to shareholders04/29/26 UPLOADLetter from the SEC05/07/25 CORRESPCorrespondence with the SEC04/30/25 ARSAnnual report to shareholders04/29/25 UPLOADLetter from the SEC04/25/25